Intravenous administration mode for lead inclusion development in mouse tissues

Area of Science:

• Toxicology
• Hepatology
• Biomedical Research

Background:

• Lead (Pb) is a toxic heavy metal with known adverse health effects.
• Understanding lead distribution and cellular targets is crucial for assessing its toxicity.
• Hepatocytes play a key role in detoxification and are susceptible to heavy metal damage.

Purpose of the Study:

• To investigate the distribution and cellular localization of lead in the liver following acute exposure.
• To characterize the formation and morphology of lead deposits within liver cells.
• To assess the utility of autoradiography for visualizing lead accumulation in hepatic tissues.

Main Methods:

• B6CF1 mice were administered an 80 mg/kg dose of lead.
• Liver lead content was quantified at one and two weeks post-injection.
• Intranuclear lead inclusions were examined using microscopy.
• Autoradiography was employed to localize lead deposits after intravenous injection of radio-labeled lead.

Main Results:

• Liver retained approximately 9.8% of the injected lead dose per gram of fresh weight after one week, decreasing to 3.9% after two weeks.
• Distinct intranuclear lead inclusions, averaging 1.6 microns in diameter, were observed in parenchymal hepatocytes.
• Autoradiography confirmed lead deposition primarily along the endothelial lining of hepatic sinusoids, with less intense signals from intranuclear inclusions.

Conclusions:

• Intravenous administration of lead results in the formation of intranuclear inclusions within parenchymal hepatocytes in B6CF1 mice.
• Lead accumulation in the liver is significant following acute exposure.
• Autoradiography is a valuable tool for studying lead distribution, though intranuclear inclusions may require specific methods for optimal visualization.